Cavitation Technologies (CVAT) reported a positive QQ3 2024 bottom line amid a very small revenue base. Revenue reached $519 thousand, up 750% year-over-year and 170% quarter-over-quarter, underscoring a meaningful top-line uptick from the previous quarters. Gross profit of $512 thousand delivered a robust gross margin of approximately 98.65%, driving an operating income of $333 thousand and net income of $331 thousand, with an EPS of $0.0012 for the quarter. The result suggests the company achieved meaningful operating leverage at the current run-rate, aided by a lean cost structure (R&D $9k, G&A $170k) and limited selling/marketing expenditure.